Floatz logo

5-FC

Digestive System Neoplasm

TransgenePhase 1/2Dormant
C
33/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
18/ 100
Competitive Position
81/ 100

Competitive context

18 Active assets in the Digestive System Neoplasm cohort.

Asset / SponsorPhaseRating
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 1CC
Dostarlimab
Elevation Oncology
Phase 1CC
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Elevation Oncology
Phase 1CC
TENATUMOMAB
sigma-tau i.f.r. S.p.A.
Phase 1CC
5-FLUOROCYTOSINE
Transgene
Phase 1/2CC

View all 21 →

Same molecule, other indications

5-FC is also rated in:

Anaplastic AstrocytomaDormant
CC
Indicative ·
43 / 100
View asset →
Glioblastoma MultiformeDormant
CC
Indicative ·
43 / 100
View asset →
Colorectal NeoplasmDormant
C
Indicative ·
33 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →